Overall, our results indicated aerosolized inhalable TPPU is a promising novel candidate for the preventative and acute treatment of asthma due to its anti-inflammatory effects, inhibition of AHR, and attenuation of airway epithelial remodeling. This evidence concerns the gene AHR and asthma.